InjectiMed Information

Is based on caring, particularly for the caregivers who treat patients where hypodermic needles are used, and for the patients receiving medical treatment. InjectiMeds mission is developing world-class, innovative technology to reduce the incidence of Needlestick Injuries (NSI) to healthcare workers, shorten access time, improve patient outcomes and address patient safety concerns. Our focus is not allowing the needle tip to be exposed when it is removed from a patient. If there is NO EXPOSURE TIME™ to a contaminated needle tip, then the probability of injury is greatly reduced. We consider our NET technology as a viable solution to solving the ongoing needlestick injury problem. DEDICATED to continuous improvement, best-practices, understanding the specific needs of the clinician and patient and offering technology designed to meet those needs. The company has designed and developed a range of safety-engineered hypodermic needles, with a focus on clinical applications. Portions of our patent portfolio have been successfully enforced by a third party in multiple jurisdictions worldwide. Our first offering from Nevada is the SafetyNET® Guidewire Introducer, an OSHA-compliant, one-handed activation surgical access needle. The company expects to develop and license additional needle platforms in the future. We are pleased to announce a 1st generation PASSIV™ Self-Capping Safety Injection Needle is functioning and has established proof-of-concept. An improved 2nd generation model, Bill of Materials and Manufacturing Plan to scale volumes have been created to continue the development. The PASSIV Safety Injection Needle is now under consideration in a pending SBIR Grant Proposal at the National Institutes of Health.